Rob from Singapore

Registered at the short selling broker Capital, 3 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Johnson & Johnson (JNJ) shares information

Johnson & Johnson

24h Change

0.04 %


Live rate: Market closed

Stock data per Monday 2 Aug, 2021

0.07 (+ 0.04%)
US Market is closed

Live Stock price in graph for Johnson & Johnson (JNJ)

  • Latest Volume

    3,721,473 (-30.4 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high

    172.84 USD

  • Today low

    171.3 USD

  • 52 week high

    173.38 USD

  • 52 week low

    131.09 USD

  • YTD Change

    + 10.83 %

Quick links


Latest news about Johnson & Johnson

Below you can find the most recent news posts about Johnson & Johnson, primarily from US and UK based news sources.

Vaccines may get authorized for young kids in October. Here are the drug companies” most likely timelines.

Tuesday, 3 August 2021, 00:40:52
Summary List Placement It”s one of the US”s biggest hurdles to getting the population vaccinated: Children under 12 nearly 15% of the country, or around 48 million Americans aren”t yet eligible to receive coronavirus shots. Both Pfizer and Moderna entered young kids into their clinical trials in March, but the results of those studies haven”t been published yet. Pfizer expects to have data about its vaccine”s efficacy among kids ages 5 to 11 by the end of September. It usually takes the Food and Drug Administration a few weeks to review such data, so that would put the US on track to start administering shots to young kids in October at the earliest, assuming the trial results are good. Data for the other age group Pfizer is studying, children ages six months to 5 years, could be available shortly thereafter, Pfizer said last month. The company previously estimated that results for its youngest age group could be available by October or November. Moderna, meanwhile, expects to seek emergency authorization for children under 12 in the winter or early next year.
— Business Insider

Baby Skincare Products Market Competitive Analysis by Pigeon, Johnson & Johnson, P&G, Unilever

Monday, 2 August 2021, 20:39:02
According to this latest study, the 2021 growth of Baby Skincare Products will have significant change from previous year. By the most conservative estimates of global Baby Skincare Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five []
— Jumbo News

Sinus Dilation Market Growth CAGR of 9.3% | Business Projected to Reach US$ 3,859.75 million by 2027 | Medtronic,Smith & Nephew,Johnson and Johnson Services, Inc.,Stryker Corporation,Intersect ENT, Inc & More

Monday, 2 August 2021, 19:58:10
The Sinus Dilation market was valued at US$ 1,918.73 million in 2019 and is projected to reach US$ 3,859.75 million by 2027; it is expected to grow at a CAGR of 9.3% during 20202027. The Insight Partners announces the research on
— OpenPR

Islay Capital Management, Llc Buys Invesco S&P 500 Equal Weight Technology ETF, Fidelity …

Monday, 2 August 2021, 18:38:10
Related Stocks: RYT , ONEQ , JNJ , PHB , RIO , WMT , FLTB , CATH , FCOR , NRGX , APLS , DNLI , HUM , IRBT , TPX , GM , URI , REZI ,
— GuruFocus

Wealthstreet Investment Advisors, LLC Buys Invesco S&P 500 Momentum ETF, Raytheon …

Monday, 2 August 2021, 18:38:06
Related Stocks: SPMO , RTX , LUV , REGN , JNJ , EL , BAC , TMO ,
— GuruFocus

Trading broker recommendation

We recommend that you check out as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: offer a large number of stocks for trading. Register an account today and check if they have JNJ available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.